Pharma stock to watch: Impax Laboratories Inc(NASDAQ: IPXL)
Impax Laboratories Inc(NASDAQ:IPXL) revenues lost 8% yoy during the fourth quarter of 2017. Given this weak top line the stock lost over 2.5% on March…
Impax Laboratories Inc(NASDAQ:IPXL) revenues lost 8% yoy during the fourth quarter of 2017. Given this weak top line the stock lost over 2.5% on March…
Cantor Fitzgerald reiterated their Overweight rating on Impax Laboratories Inc(NASDAQ: IPXL) and Horizon Pharma PLC(NASDAQ: a weak Total revenuesHZNP) The brokerage firm is bullish on…